First Time Loading...

Medexus Pharmaceuticals Inc
TSX:MDP

Watchlist Manager
Medexus Pharmaceuticals Inc Logo
Medexus Pharmaceuticals Inc
TSX:MDP
Watchlist
Price: 1.79 CAD 1.13% Market Closed
Updated: May 5, 2024

Medexus Pharmaceuticals Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medexus Pharmaceuticals Inc
Operating Income Peer Comparison

Comparables:
BHC
WEED
CRON
C
CURA
T
TER

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Medexus Pharmaceuticals Inc
TSX:MDP
Operating Income
$12.8m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Operating Income
$1.6B
CAGR 3-Years
7%
CAGR 5-Years
26%
CAGR 10-Years
6%
Canopy Growth Corp
TSX:WEED
Operating Income
-CA$337.4m
CAGR 3-Years
25%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Operating Income
-$79.9m
CAGR 3-Years
22%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Operating Income
$12.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Terrascend Corp
CNSX:TER
Operating Income
-$23.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Medexus Pharmaceuticals Inc's Operating Income?
Operating Income
12.8m USD

Based on the financial report for Dec 31, 2023, Medexus Pharmaceuticals Inc's Operating Income amounts to 12.8m USD.

What is Medexus Pharmaceuticals Inc's Operating Income growth rate?
Operating Income CAGR 3Y
26%

Over the last year, the Operating Income growth was 194%. The average annual Operating Income growth rates for Medexus Pharmaceuticals Inc have been 26% over the past three years .